FALZETTI, Franca
 Distribuzione geografica
Continente #
NA - Nord America 2.106
EU - Europa 1.872
AS - Asia 406
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 4.390
Nazione #
US - Stati Uniti d'America 2.101
IT - Italia 486
IE - Irlanda 443
UA - Ucraina 239
SE - Svezia 218
HK - Hong Kong 195
DE - Germania 113
FI - Finlandia 97
VN - Vietnam 86
CN - Cina 83
RU - Federazione Russa 78
GB - Regno Unito 58
FR - Francia 42
RO - Romania 40
BE - Belgio 23
TR - Turchia 22
CH - Svizzera 9
UZ - Uzbekistan 8
AT - Austria 7
LB - Libano 5
NL - Olanda 5
PL - Polonia 5
CA - Canada 4
GR - Grecia 4
EU - Europa 2
KR - Corea 2
SG - Singapore 2
AU - Australia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
GH - Ghana 1
ID - Indonesia 1
IM - Isola di Man 1
IN - India 1
MX - Messico 1
TW - Taiwan 1
Totale 4.390
Città #
Chandler 499
Dublin 443
San Mateo 299
Perugia 229
Hong Kong 195
Jacksonville 136
Ann Arbor 111
Dong Ket 86
Medford 85
Princeton 83
Altamura 78
Andover 69
Beijing 61
Lawrence 58
Wilmington 55
Bucharest 40
Helsinki 31
Foligno 27
Houston 24
Saint Petersburg 24
Brussels 23
New York 23
Dearborn 22
Des Moines 21
Izmir 21
Los Angeles 21
Redwood City 21
Norwalk 20
San Paolo di Civitate 13
Ashburn 11
Assisi 10
Falls Church 10
Redmond 10
West Jordan 10
Woodbridge 10
Auburn Hills 8
Moscow 8
Shanghai 8
Bastia 4
Boardman 4
Rome 4
Spello 4
Ancona 3
Aurora 3
Den Haag 3
Florence 3
Frankfurt Am Main 3
Gradara 3
Guangzhou 3
Milan 3
Ottawa 3
Padova 3
Scafa 3
Vienna 3
Vigodarzere 3
Bologna 2
Changsha 2
Chicago 2
Kunming 2
Ludwigshafen 2
Macerata 2
Melissa 2
Mirano 2
Selargius 2
Seoul 2
Abidjan 1
Allentown 1
Amsterdam 1
Apo 1
Athens 1
Battipaglia 1
Bekasi 1
Cagliari 1
Campobasso 1
Catania 1
Civitanova Marche 1
Comano 1
Copenhagen 1
Dallas 1
Douglas 1
Fremont 1
Groningen 1
Grosseto 1
Hefei 1
Jinan 1
Kocaeli 1
L'aquila 1
Lappeenranta 1
Latina 1
London 1
Madrid 1
Manchester 1
Montreal 1
Nanjing 1
Paris 1
Piediluco 1
Ponso 1
Porto Torres 1
San Benedetto Del Tronto 1
San Diego 1
Totale 3.013
Nome #
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 120
Advances in full-haplotype mismatched transplants in acute leukemia 118
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 108
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 107
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 102
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 89
Mesenchymal cells: a vehicle for gene therapy 84
Graft engineering for allogeneic haploidentical stem cell transplantation 82
In Vivo Real Time Monitoring of Stem Cells Homing in Postischemic Tissues 81
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 80
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 75
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 75
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 72
IN VIVO DIRECT MONITORING OF STEM CELLS HOMING IN POSTISCHEMIC TISSUES 68
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 66
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 65
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 65
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 65
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 64
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 63
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 62
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 61
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 61
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 61
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 60
T regulatory cell separation for clinical application. 60
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 60
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 59
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 59
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 58
Stem cell mobilization in normal donors. 57
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 57
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 56
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 56
Effetto della severità dell'ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicroscopia 54
Effetto della severità dell’ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicrosopia. 53
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 52
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 51
Full haplotype mismatched transplant in high risk acute leukemia patients. 50
Mismatched hematopoietic stem cell transplantation in secondary leukemia 50
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 50
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 50
Distribution of active alpha and beta subunit of beta-N-acetylhexosaminidase as a function of leukaemic cell types 48
MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 V617F positive primary myelofibrosis 48
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 48
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 48
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 48
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 48
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 47
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 46
"Designed" grafts for HLA-haploidentical stem cell transplantation. 46
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 46
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 46
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 46
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 45
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 45
New mechanism of lymphoma-induced bone marrow aplasia 45
MOLECULAR AND BIOLOGICAL BASIS OF THE ASOCIATION OF RADIOTHERAPY, 5-FLUOROURACIL AND GEFITINIB IN RECTAL CANCER 44
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 43
. Mismatched hematopoietic stem cell transplants in elderly patients. 42
Identification and Characterization of Novel Rare Nucleophosmin (NPM1) Gene Mutations in Acute Myeloid Leukemia (AML) By a Combinatorial Approach of Immunohistochemistry and Molecular Analyses 41
THE BRAF INHIBITOR VEMURAFENIB IS SAFE AND HIGHLY EFFECTIVE IN REFRACTORY AND RELAPSED HAIRY CELL LEUKEMIA: RESULTS OF THE HCL-PG01 PHASE-2 ITALIAN CLINICAL TRIAL 41
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 41
Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era 40
Reclutamento delle cellule staminali nei tessuti postischemici: valutazione diretta in vivo mediante videomicroscopia 40
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 40
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. 39
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 38
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 37
null 37
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 37
Mesenchymal cells recruit and regulate T regulatory cells. 36
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 36
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 35
Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line. 35
Trapianto di cellule staminali nei tessuti post-ischemici: studio in vivo degli effetti delle cellule staminali sulla funzione microvascolare. 35
NOTCH and Graft-Versus-Host Disease 30
Homing and survival of thimidine kinase transduced human T-cells in NOD/SCID mice. 29
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 29
Next generation HLA-haploidentical HSCT 27
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 26
Radioimmunotherapy with 90Y-ibritumomab tiuxetan to treat follicular non Hodgkin-lymphoma in relapse after autologous transplant or refractory to chemotherapy: preliminary results. 25
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 22
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 21
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 20
Uno strano caso di “eritema pernio” delle mani 20
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 20
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 18
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 12
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 11
Totale 4.633
Categoria #
all - tutte 16.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.462


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201956 0 0 0 0 0 0 0 0 0 15 38 3
2019/2020420 18 8 42 9 40 24 47 19 56 102 14 41
2020/2021690 12 33 32 35 194 58 51 12 78 26 59 100
2021/2022974 18 252 18 43 22 10 14 223 12 77 138 147
2022/20231.471 89 275 15 129 119 150 0 61 558 6 49 20
2023/2024459 30 69 37 29 3 20 178 9 46 38 0 0
Totale 4.633